Clinical Trial

Radiomics-based Malnutrition for Cervical Cancer.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Loss of skeletal muscle, is one of the most prevalent symptoms of malnutrition, and has been frequently reported as a negative factor in cancer patients at any disease stage. In this study, we are planning to firstly analyze the radiomics features of psoas extracted at the level of the third lumbar vertebra (L3) and then, develop a CT-based radiomics nomogram prediction model for predicting malnutrition based on their Patient-Generated Subjective Global Assessment (PG-SGA) scores in patients with International Federation of Gynecology and Obstetrics (FIGO, 2014 version) stage IB1-IIA2 cervical cancer (CC) who received postoperative radiotherapy/chemoradiotherapy (RT/CRT).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-01-24.
Status change: Not Yet Recruiting → Recruiting 2023-07-17
Trial Details
NCT Number NCT05709769
Lead Sponsor Zhejiang Provincial People's Hospital
Conditions Cervical Cancer, Malnutrition
Enrollment 150 participants
Start Date 2023-01-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-07-20